General Announcement::Announcement by TMC Life Sciences Berhad, 4Q2022 and full year audited results

Issuer & Securities

Issuer/ Manager
THOMSON MEDICAL GROUP LIMITED
Securities
THOMSON MED S$175M4.05%N250128 - SGXF89249654 - RMEB
THOMSON MEDICAL GROUP LIMITED - SG1M49904634 - A50
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
23-Aug-2022 18:25:23
Status
New
Announcement Sub Title
Announcement by TMC Life Sciences Berhad, 4Q2022 and full year audited results
Announcement Reference
SG220823OTHRM1JD
Submitted By (Co./ Ind. Name)
Dr Wong Chiang Yin
Designation
Executive Director and Group Chief Executive Officer
Description (Please provide a detailed description of the event in the box below)
Please see attached.

Attachments

TMCLS AFS-30.06.2022.pdf
TMCLS Announcement_Q4 2022-Final.pdf
Total size =2171K